946159-38-2

Usage

Type

Research chemical

Psychoactive effects

Yes

Derivative of

Phencyclidine (PCP)

Classification

Designer drug

Mechanism of action

NMDA receptor antagonist

Effects

Hallucinogenic, sedative, dissociation, euphoria, altered perception of time and space

Health risks

Addiction, negative psychological effects, overdose

Medical use

Not approved

Legal status

Illegal in many jurisdictions

Upstream product

• 104-92-7 1-bromo-4-methoxy-benzene 
• 40114-49-6 1-benzyl-3-piperidone 
• 557-91-5 1,1-Dibromoethane 
• 13139-86-1 4-methoxyphenyl magnesium bromide 

Downstream Products

• 66970-69-2 1-benzyl-3,3-bis-(4-methoxy-phenyl)-piperidine 
• 19725-26-9 3-(4-methoxyphenyl)-piperidinehydrochloride 

Relevant academic research and scientific papers

Selective NR2B Antagonists

The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands of the NR2B receptor and may be useful for the treatment of various disorders of the c

COMPOUNDS AND COMPOSITIONS AS LXR MODULATORS

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of liver X receptors (LXRs).

Novel 7-hydroxy-indoles

Novel 7-hydroxy-indoles of the formula STR1 wherein R is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms, cycloalkylalkyl of 4 to 7 carbon atoms and aralkyl of 7 to 12 carbon atoms optionally substituted by one or more members